Skip to main content
. 2021 Apr 20;104(2):00368504211010938. doi: 10.1177/00368504211010938

Figure 5.

Figure 5.

Prognostic relevance of CD133 methylation levels across different types of tumor: (a) Spearman correlations of CD133 expression levels and CD133 methylation levels in patients with LGG, PRCC, GBM, or HNSC in TCGA datasets were determined, and (b) overall survival was determined in CD133 hypermethylated (red) and CD133 hypomethylated patients (blue) in LGG, GBM, BLCA, LAML, PRCC, HNSC, ACC, or KIRC. P value was generated from Log-rank test.